Efficacy of Oral Progesterone and Vaginal Progesterone After Tocolytic Therapy in Threatened Preterm Labor
NCT02989519 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 231
Last updated 2017-10-10
Summary
The purpose of this study is to determine efficacy of vaginal and oral progesterone after tocolytic therapy in threatened preterm labor
Conditions
- Preterm Delivery
Interventions
- DRUG
-
dydrogesterone
- DRUG
-
Micronized progesterone
Sponsors & Collaborators
-
Sanpasitthiprasong Hospital
lead OTHER_GOV
Principal Investigators
-
Piyawadee Wuttikonsammakit, MD · Instructor
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-08-31
- Primary Completion
- 2017-01-05
- Completion
- 2017-03-01
Countries
- Thailand
More Related Trials
-
Vaginal Progesterone for the Prevention of Preterm Birth in Women With Arrested Preterm Labor
NCT01840228 ·Status: TERMINATED ·Phase: NA
-
Vaginal Progesterone for Prevention of Preterm Birth After an Episode of Preterm Labor
NCT01523483 ·Status: COMPLETED ·Phase: NA
-
Oral Dydrogesterone in the Management of Preterm Labor
NCT03935152 ·Status: COMPLETED ·Phase: PHASE4
-
Progestagens for the Tertiary Prophylaxis of Preterm Delivery
NCT01178788 ·Status: COMPLETED ·Phase: PHASE3
-
Comparing IM vs. Vaginal Progesterone for Pre-term Birth
NCT00579553 ·Status: COMPLETED ·Phase: NA
-
Vaginal Compared With Intramuscular Progesterone for Prevention of Preterm Birth in High Risk Pregnant Women
NCT02304237 ·Status: UNKNOWN ·Phase: PHASE3
-
An Electronic Medical Record Alert of Progesterone
NCT03219489 ·Status: COMPLETED ·Phase: NA
-
Comparison in Cervical Length and Prolongation of Gestation Age on Vaginal Progesterone Administration to Pregnant Women After the Acute Phase of Threatened Preterm Birth
NCT06975943 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Prevention of Preterm Labor in Patients With a Previous Episode of Threatened Preterm Labor With Progesterone
NCT01317225 ·Status: UNKNOWN ·Phase: PHASE3
-
Vaginal Progesterone as a Treatment for Women Active Preterm Labor
NCT01206998 ·Status: WITHDRAWN ·Phase: NA
-
Randomized Controlled Trial of Vaginal Progesterone in Women With Threatened Preterm Labor
NCT01286246 ·Status: TERMINATED ·Phase: PHASE4
-
Vaginal Progesterone for the Prolongation of Pregnancy After Arrested Pre-term Labor
NCT02430233 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery
NCT02225353 ·Status: COMPLETED ·Phase: PHASE2
-
Cervical Ripening Before Induction of Labour at Term: a Randomised Comparison of Prostin vs Propess
NCT00545194 ·Status: WITHDRAWN ·Phase: PHASE3
-
Utility of Tocolytic Therapy for Maintenance Tocolysis in the Management of Threatened Preterm Delivery
NCT01796522 ·Status: WITHDRAWN ·Phase: PHASE3
-
Vaginal PROgesterone as Maintenance Treatment After an epISode of prEterm Labor (PROMISE Study)
NCT00646802 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison Between Natural Progesterone and Vaginal Pessary for the Prevention of Spontaneous Preterm Birth
NCT02511574 ·Status: COMPLETED ·Phase: PHASE4
-
Oral Versus Parental Progesterone in the Management of Preterm Labor
NCT03343795 ·Status: COMPLETED ·Phase: PHASE4
-
Vaginal Progesterone for Prevention of Preterm Labor in Asymptomatic Twin Pregnancies With Sonographic Short Cervix
NCT02338830 ·Status: COMPLETED ·Phase: PHASE4
-
Vaginal Progesterone to Reduce the Risk of Another Preterm Birth
NCT00086177 ·Status: COMPLETED ·Phase: PHASE3
-
Does Progesterone Prevent Very Preterm Delivery in Twin Pregnancies?
NCT00329914 ·Status: COMPLETED ·Phase: PHASE2
-
Vaginal Progesterone Versus 17-Alpha-Hydroxyprogesterone Caproate in Placenta Previa
NCT03779451 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of 17 Alpha-hydroxyprogesterones Caproate for the Prevention of Preterm Delivery
NCT00331695 ·Status: COMPLETED ·Phase: PHASE4
-
Different Types of Progesterone in the Prevention of Preterm Labor
NCT03537287 ·Status: UNKNOWN ·Phase: PHASE2
-
Progesterone to Prevent Preterm Delivery
NCT03428685 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3